556 related articles for article (PubMed ID: 15984315)
21. Value of component based diagnostics in IgE-mediated hymenoptera sting reactions.
Neis MM; Merk HF
Cutan Ocul Toxicol; 2012 Jun; 31(2):117-23. PubMed ID: 21995714
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of Hymenoptera venom allergy.
Biló BM; Rueff F; Mosbech H; Bonifazi F; Oude-Elberink JN;
Allergy; 2005 Nov; 60(11):1339-49. PubMed ID: 16197464
[TBL] [Abstract][Full Text] [Related]
23. Component-resolved diagnosis in vespid venom-allergic individuals.
Galindo-Bonilla PA; Galán-Nieto A; Alfaya-Arias T; García-Rodríguez C; de la Roca-Pinzón F; Feo-Brito F
Allergol Immunopathol (Madr); 2015; 43(4):398-402. PubMed ID: 25192862
[TBL] [Abstract][Full Text] [Related]
24. Cross-Reactive Carbohydrate Determinant in
Abram DM; Fernandes LGR; Perez-Riverol A; Regina Brochetto-Braga M; Zollner RL
Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33050082
[TBL] [Abstract][Full Text] [Related]
25. Humoral immunological response in patients with venom allergy during specific immunotherapy.
Szymański W; Chyrek-Borowska S
Rocz Akad Med Bialymst; 1995; 40(2):376-82. PubMed ID: 8834621
[TBL] [Abstract][Full Text] [Related]
26. Adverse reactions to venom immunotherapy.
Ramirez DA; Londono S; Evans R
Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
[TBL] [Abstract][Full Text] [Related]
27. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
Pereira-Santos MC; Baptista AP; Melo A; Alves RR; Soares RS; Pedro E; Pereira-Barbosa M; Victorino RM; Sousa AE
Clin Exp Allergy; 2008 Feb; 38(2):291-7. PubMed ID: 18070166
[TBL] [Abstract][Full Text] [Related]
28. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
[TBL] [Abstract][Full Text] [Related]
29. The sting challenge test in Hymenoptera venom allergy: pros and cons.
Bilò MB; Brianzoni MF; Garritani MS; Antonicelli L; Farabollini B; Bonifazi F
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):377-81. PubMed ID: 14768522
[TBL] [Abstract][Full Text] [Related]
30. Systemic and local reactions of bee venom immunotherapy in Iran.
Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and biological surveillance after the cessation of Hymenoptera venom desensitization].
Touraine F; Talayrach D; Florea O; Brianchon Ch; Preux PM; Bonnaud F
Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):335-9. PubMed ID: 14716961
[TBL] [Abstract][Full Text] [Related]
32. The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy.
Erdmann SM; Sachs B; Kwiecien R; Moll-Slodowy S; Sauer I; Merk HF
Allergy; 2004 Oct; 59(10):1102-9. PubMed ID: 15355470
[TBL] [Abstract][Full Text] [Related]
33. IgE antibodies to Hymenoptera venoms in the serum are common in the general population and are related to indications of atopy.
Schäfer T; Przybilla B
Allergy; 1996 Jun; 51(6):372-7. PubMed ID: 8837658
[TBL] [Abstract][Full Text] [Related]
34. Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy.
Sturm GJ; Heinemann A; Schuster C; Wiednig M; Groselj-Strele A; Sturm EM; Aberer W
Allergy; 2007 Aug; 62(8):884-9. PubMed ID: 17620065
[TBL] [Abstract][Full Text] [Related]
35. [The wasp/mosquito syndrome].
Sabbah A; Hassoun S; Drouet M; Lauret MG; Doucet M
Allerg Immunol (Paris); 1999 Jun; 31(6):175-84. PubMed ID: 10443298
[TBL] [Abstract][Full Text] [Related]
36. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
von Moos S; Graf N; Johansen P; Müllner G; Kündig TM; Senti G
Int Arch Allergy Immunol; 2013; 160(1):86-92. PubMed ID: 22948338
[TBL] [Abstract][Full Text] [Related]
37. Allergens in hymenoptera venom. VIII. Immunologic comparison of venoms from six species of Vespula (yellow jackets).
Hoffman DR; McDonald CA
Ann Allergy; 1982 Feb; 48(2):78-81. PubMed ID: 7065470
[TBL] [Abstract][Full Text] [Related]
38. Component-resolved diagnosis of vespid venom-allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitization.
Monsalve RI; Vega A; Marqués L; Miranda A; Fernández J; Soriano V; Cruz S; Domínguez-Noche C; Sánchez-Morillas L; Armisen-Gil M; Guspí R; Barber D
Allergy; 2012 Apr; 67(4):528-36. PubMed ID: 22229815
[TBL] [Abstract][Full Text] [Related]
39. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
Gawlik R; Glück J; Jawor B; Rogala B
Immunopharmacol Immunotoxicol; 2015; 37(4):375-9. PubMed ID: 26181651
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of Hymenoptera venom allergy and its immunological markers current in adults in Poland.
Nittner-Marszalska M; Liebhart J; Liebhart E; Dor A; Dobek R; Obojski A; Medrala W
Med Sci Monit; 2004 Jul; 10(7):CR324-9. PubMed ID: 15232507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
